AAAAAA

   
Results: 1-25 | 26-50 | 51-75 | 76-85
Results: 1-25/85
LORICRIN-LESS CELL ENVELOPES - A BACKUP SYSTEM IN LORICRIN KNOCKOUT MICE
Authors: JAMIK M DEVIRAGH PA BUNDMAN D ROOP DR STEVEN AC
Citation: M. Jamik et al., LORICRIN-LESS CELL ENVELOPES - A BACKUP SYSTEM IN LORICRIN KNOCKOUT MICE, Molecular biology of the cell, 9, 1998, pp. 423-423
EXPRESSION OF A P53 MUTANT IN THE EPIDERMIS OF TRANSGENIC MICE ACCELERATES CHEMICAL CARCINOGENESIS
Authors: WANG XJ GREENHALGH DA JIANG AB HE DC ZHONG L MEDINA D BRINKLEY BR ROOP DR
Citation: Xj. Wang et al., EXPRESSION OF A P53 MUTANT IN THE EPIDERMIS OF TRANSGENIC MICE ACCELERATES CHEMICAL CARCINOGENESIS, Oncogene, 17(1), 1998, pp. 35-45
ANALYSIS OF CENTROSOME ABNORMALITIES AND ANGIOGENESIS IN EPIDERMAL-TARGETED P53(172H) MUTANT AND P53-KNOCKOUT MICE AFTER CHEMICAL CARCINOGENESIS - EVIDENCE FOR A GAIN OF FUNCTION
Authors: WANG XJ GREENHALGH DA JIANG A HE DC ZHONG L BRINKLEY BR ROOP DR
Citation: Xj. Wang et al., ANALYSIS OF CENTROSOME ABNORMALITIES AND ANGIOGENESIS IN EPIDERMAL-TARGETED P53(172H) MUTANT AND P53-KNOCKOUT MICE AFTER CHEMICAL CARCINOGENESIS - EVIDENCE FOR A GAIN OF FUNCTION, Molecular carcinogenesis (Print), 23(3), 1998, pp. 185-192
PRENATAL-DIAGNOSIS FOR KERATIN MUTATIONS TO EXCLUDE TRANSMISSION OF EPIDERMOLYTIC HYPERKERATOSIS
Authors: ROTHNAGEL JA LIN MTS LONGLEY MA HOLDER RA HAZEN PG LEVY ML ROOP DR
Citation: Ja. Rothnagel et al., PRENATAL-DIAGNOSIS FOR KERATIN MUTATIONS TO EXCLUDE TRANSMISSION OF EPIDERMOLYTIC HYPERKERATOSIS, Prenatal diagnosis, 18(8), 1998, pp. 826-830
EX-VIVO AND IN-VIVO ADENOVIRUS-MEDIATED GENE-THERAPY STRATEGIES INDUCE A SYSTEMIC ANTITUMOR IMMUNE DEFENSE IN THE B16 MELANOMA MODEL
Authors: BONNEKOH B GREENHALGH DA CHEN SH BLOCK A RICH SS KRIEG T WOO SLC ROOP DR
Citation: B. Bonnekoh et al., EX-VIVO AND IN-VIVO ADENOVIRUS-MEDIATED GENE-THERAPY STRATEGIES INDUCE A SYSTEMIC ANTITUMOR IMMUNE DEFENSE IN THE B16 MELANOMA MODEL, Journal of investigative dermatology, 110(6), 1998, pp. 867-871
DEVELOPMENT OF GENE-SWITCH TRANSGENIC MICE WHICH INDUCIBLY EXPRESS TRANSFORMING-GROWTH-FACTOR BETA-1 (TGF-BETA-1) IN THE EPIDERMIS
Authors: WANG XJ LIEFER KM ROOP DR
Citation: Xj. Wang et al., DEVELOPMENT OF GENE-SWITCH TRANSGENIC MICE WHICH INDUCIBLY EXPRESS TRANSFORMING-GROWTH-FACTOR BETA-1 (TGF-BETA-1) IN THE EPIDERMIS, Journal of investigative dermatology, 110(4), 1998, pp. 473-473
ACTIVATED RAS(HA) EXPRESSION IS NECESSARY TO OVERCOME A PARADOXICAL TUMOR INHIBITORY EFFECT OF P53 LOSS IN TRANSGENIC MOUSE EPIDERMIS
Authors: GREENHALGH DA WANG XJ ROOP DR
Citation: Da. Greenhalgh et al., ACTIVATED RAS(HA) EXPRESSION IS NECESSARY TO OVERCOME A PARADOXICAL TUMOR INHIBITORY EFFECT OF P53 LOSS IN TRANSGENIC MOUSE EPIDERMIS, Journal of investigative dermatology, 110(4), 1998, pp. 498-498
IMMUNOLOGICAL GENE-THERAPY APPROACHES FOR MALIGNANT-MELANOMA .2. PRECLINICAL STUDIES AND CLINICAL STRATEGIES
Authors: BONNEKOH B BICKENBACH JR ROOP DR
Citation: B. Bonnekoh et al., IMMUNOLOGICAL GENE-THERAPY APPROACHES FOR MALIGNANT-MELANOMA .2. PRECLINICAL STUDIES AND CLINICAL STRATEGIES, Skin pharmacology, 10(3), 1997, pp. 105-125
IMMUNOLOGICAL GENE-THERAPY APPROACHES FOR MALIGNANT-MELANOMA .1. TUMOR-IMMUNOLOGICAL BACKGROUND
Authors: BONNEKOH B BICKENBACH JR ROOP DR
Citation: B. Bonnekoh et al., IMMUNOLOGICAL GENE-THERAPY APPROACHES FOR MALIGNANT-MELANOMA .1. TUMOR-IMMUNOLOGICAL BACKGROUND, Skin pharmacology, 10(2), 1997, pp. 49-62
ADENOVIRUS-MEDIATED EX-VIVO IMMUNOGENE AND IN-VIVO COMBINATION GENE-THERAPY STRATEGIES INDUCE A SYSTEMIC ANTITUMOR IMMUNE DEFENSE IN THE MOUSE B16 MELANOMA MODEL
Authors: BONNEKOH B GREENHALGH DA CHEN SH BICKENBACH J BLOCK A RICH SS KRIEG T WOO SLC ROOP DR
Citation: B. Bonnekoh et al., ADENOVIRUS-MEDIATED EX-VIVO IMMUNOGENE AND IN-VIVO COMBINATION GENE-THERAPY STRATEGIES INDUCE A SYSTEMIC ANTITUMOR IMMUNE DEFENSE IN THE MOUSE B16 MELANOMA MODEL, Cancer gene therapy, 4(5), 1997, pp. 305-305
INHIBITION OF RETINOID SIGNALING IN TRANSGENIC MICE ALTERS LIPID PROCESSING AND DISRUPTS EPIDERMAL BARRIER FUNCTION
Authors: ATTAR PS WERTZ PW MCARTHUR M IMAKADO S BICKENBACH JR ROOP DR
Citation: Ps. Attar et al., INHIBITION OF RETINOID SIGNALING IN TRANSGENIC MICE ALTERS LIPID PROCESSING AND DISRUPTS EPIDERMAL BARRIER FUNCTION, Molecular endocrinology, 11(6), 1997, pp. 792-800
EXPRESSION OF A DOMINANT-NEGATIVE TYPE-II TRANSFORMING GROWTH-FACTOR-BETA (TGF-BETA) RECEPTOR IN THE EPIDERMIS OF TRANSGENIC MICE BLOCKS TGF-BETA-MEDIATED GROWTH-INHIBITION
Authors: WANG XJ GREENHALGH DA BICKENBACH JR JIANG AB BUNDMAN DS KRIEG T DERYNCK R ROOP DR
Citation: Xj. Wang et al., EXPRESSION OF A DOMINANT-NEGATIVE TYPE-II TRANSFORMING GROWTH-FACTOR-BETA (TGF-BETA) RECEPTOR IN THE EPIDERMIS OF TRANSGENIC MICE BLOCKS TGF-BETA-MEDIATED GROWTH-INHIBITION, Proceedings of the National Academy of Sciences of the United Statesof America, 94(6), 1997, pp. 2386-2391
VACCINATION WITH MELANOMA-CELLS XENOGENIZED BY A RECOMBINANT ADENOVIRUS PROVIDES A PROTECTION AGAINST TUMOR CHALLENGE IN THE MURINE K1735 MODEL
Authors: BONNEKOH B GREENHALGH DA CHEN SH WOO SLC ROOP DR
Citation: B. Bonnekoh et al., VACCINATION WITH MELANOMA-CELLS XENOGENIZED BY A RECOMBINANT ADENOVIRUS PROVIDES A PROTECTION AGAINST TUMOR CHALLENGE IN THE MURINE K1735 MODEL, Journal of investigative dermatology, 109(3), 1997, pp. 417-417
EXPRESSION OF A MUTANT FORM OF P53 IN THE EPIDERMIS OF TRANSGENIC MICE - EVIDENCE FOR A GAIN-OF-FUNCTION
Authors: WANG XJ JIANG AB GREENHALGH DA ROOP DR
Citation: Xj. Wang et al., EXPRESSION OF A MUTANT FORM OF P53 IN THE EPIDERMIS OF TRANSGENIC MICE - EVIDENCE FOR A GAIN-OF-FUNCTION, Journal of investigative dermatology, 108(4), 1997, pp. 45-45
GROWTH OF SELECTED EPIDERMAL STEM-CELLS
Authors: BICKENBACH JR ROOP DR
Citation: Jr. Bickenbach et Dr. Roop, GROWTH OF SELECTED EPIDERMAL STEM-CELLS, Journal of investigative dermatology, 108(4), 1997, pp. 68-68
LORICRIN DEFICIENT MICE - UP-REGULATION OF OTHER CELL-ENVELOPE PRECURSORS RESCUES THE NEONATAL DEFECT BUT FAILS TO RESTORE EPIDERMAL BARRIER FUNCTION
Authors: DEVIRAGH PA SCHARER L BUNDMAN D ROOP DR
Citation: Pa. Deviragh et al., LORICRIN DEFICIENT MICE - UP-REGULATION OF OTHER CELL-ENVELOPE PRECURSORS RESCUES THE NEONATAL DEFECT BUT FAILS TO RESTORE EPIDERMAL BARRIER FUNCTION, Journal of investigative dermatology, 108(4), 1997, pp. 103-103
A NOVEL DINUCLEOTIDE MUTATION IN KERATIN-10 IN THE ANNULAR EPIDERMOLYTIC ICHTHYOSIS VARIANT OF BULLOUS CONGENITAL ICHTHYOSIFORM ERYTHRODERMA
Authors: JOH GY TRAUPE H METZE D NASHAN D HUBER M HOHL D LONGLEY MA ROTHNAGEL JA ROOP DR
Citation: Gy. Joh et al., A NOVEL DINUCLEOTIDE MUTATION IN KERATIN-10 IN THE ANNULAR EPIDERMOLYTIC ICHTHYOSIS VARIANT OF BULLOUS CONGENITAL ICHTHYOSIFORM ERYTHRODERMA, Journal of investigative dermatology, 108(3), 1997, pp. 357-361
A ROLE FOR TGF-BETA-1 IN LANGERHANS CELL BIOLOGY - FURTHER CHARACTERIZATION OF THE EPIDERMAL LANGERHANS CELL DEFECT IN TGF-BETA-1 NULL MICE
Authors: BORKOWSKI TA LETTERIO JJ MACKALL CL SAITOH A WANG XJ ROOP DR GRESS RE UDEY MC
Citation: Ta. Borkowski et al., A ROLE FOR TGF-BETA-1 IN LANGERHANS CELL BIOLOGY - FURTHER CHARACTERIZATION OF THE EPIDERMAL LANGERHANS CELL DEFECT IN TGF-BETA-1 NULL MICE, The Journal of clinical investigation, 100(3), 1997, pp. 575-581
TARGETED DELETION (KNOCKOUT) OF THE LORICRIN GENE - RESCUE OF THE CORNIFIED ENVELOPE BY UP-REGULATION OF MINOR PRECURSORS
Authors: DEVIRAGH PA SCHARER L BUNDMAN D ROOP DR
Citation: Pa. Deviragh et al., TARGETED DELETION (KNOCKOUT) OF THE LORICRIN GENE - RESCUE OF THE CORNIFIED ENVELOPE BY UP-REGULATION OF MINOR PRECURSORS, Dermatology, 193(2), 1996, pp. 165-165
A TRANSGENIC MOUSE MODEL THAT RECAPITULATES THE CLINICAL-FEATURES OF BOTH NEONATAL AND ADULT FORMS OF THE SKIN-DISEASE EPIDERMOLYTIC HYPERKERATOSIS
Authors: BICKENBACH JR LONGLEY MA BUNDMAN DS DOMINEY AM BOWDEN PE ROTHNAGEL JA ROOP DR
Citation: Jr. Bickenbach et al., A TRANSGENIC MOUSE MODEL THAT RECAPITULATES THE CLINICAL-FEATURES OF BOTH NEONATAL AND ADULT FORMS OF THE SKIN-DISEASE EPIDERMOLYTIC HYPERKERATOSIS, Differentiation, 61(2), 1996, pp. 129-139
APOLIPOPROTEIN-E PRODUCED BY AN EPIDERMAL SPECIFIC PROMOTER IN TRANSGENIC MICE - A FEASIBILITY STUDY FOR KERATINOCYTE GENE-THERAPY
Authors: JONES CH ROOP DR
Citation: Ch. Jones et Dr. Roop, APOLIPOPROTEIN-E PRODUCED BY AN EPIDERMAL SPECIFIC PROMOTER IN TRANSGENIC MICE - A FEASIBILITY STUDY FOR KERATINOCYTE GENE-THERAPY, Pediatric research, 39(4), 1996, pp. 1300-1300
NOVEL ALTERNATIVE GENETIC THERAPIES - POSSIBLE LINKS TO EB
Authors: ROOP DR BICKENBACH JR
Citation: Dr. Roop et Jr. Bickenbach, NOVEL ALTERNATIVE GENETIC THERAPIES - POSSIBLE LINKS TO EB, Journal of investigative dermatology, 107(5), 1996, pp. 18-18
TRANSIENT CONGENITAL ERYTHRODERMA IN LORICRIN DEFICIENT MICE
Authors: DEVIRAGH PA SCHARER L BUNDMAN D ROOP DR
Citation: Pa. Deviragh et al., TRANSIENT CONGENITAL ERYTHRODERMA IN LORICRIN DEFICIENT MICE, Journal of investigative dermatology, 107(3), 1996, pp. 4-4
EXPRESSION OF A DOMINANT-NEGATIVE TYPE-II TGF-BETA RECEPTOR IN THE EPIDERMIS OF TRANSGENIC MICE DOCUMENTS ITS ROLE IN MEDIATING GROWTH-INHIBITION
Authors: WANG XJ GREENHALGH DA BICKENBACH JA BUNDMAN DS DERYNCK R ROOP DR
Citation: Xj. Wang et al., EXPRESSION OF A DOMINANT-NEGATIVE TYPE-II TGF-BETA RECEPTOR IN THE EPIDERMIS OF TRANSGENIC MICE DOCUMENTS ITS ROLE IN MEDIATING GROWTH-INHIBITION, Journal of investigative dermatology, 107(1), 1996, pp. 144-144
ADENOVIRAL-MEDIATED HERPES-SIMPLEX VIRUS-THYMIDINE KINASE GENE-TRANSFER IN-VIVO FOR TREATMENT OF EXPERIMENTAL HUMAN-MELANOMA
Authors: BONNEKOH B GREENHALGH DA BUNDMAN DS KOSAI K CHEN SH FINEGOLD MJ KRIEG T WOO SLC ROOP DR
Citation: B. Bonnekoh et al., ADENOVIRAL-MEDIATED HERPES-SIMPLEX VIRUS-THYMIDINE KINASE GENE-TRANSFER IN-VIVO FOR TREATMENT OF EXPERIMENTAL HUMAN-MELANOMA, Journal of investigative dermatology, 106(6), 1996, pp. 1163-1168
Risultati: 1-25 | 26-50 | 51-75 | 76-85